临床试验

Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

NCT：NCT07589387 · NOT_YET_RECRUITING

NCT编号NCT07589387

状态NOT_YET_RECRUITING

开始日期2026-05-01

完成时间2030-01-31

SponsorWashington University School of Medicine (OTHER)

First posted2026-05-15

Last updated2026-05-15

简要摘要

The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory (FCT). This program demonstrated significant improvements in hypertension treatment and control. The focus of aim 3 will be evaluating diabetes management through the implementation of the HEARTS-D bundle in 10 PHCs across the FCT that previously participated in the initial HTN Program.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。